Published online Dec 16, 2017. doi: 10.12998/wjcc.v5.i12.412
Peer-review started: August 8, 2017
First decision: September 20, 2017
Revised: September 27, 2017
Accepted: October 29, 2017
Article in press: October 29, 2017
Published online: December 16, 2017
Processing time: 124 Days and 19.7 Hours
The relationship between Helicobacter pylori (H. pylori) infection and various extra-gastrointestinal symptoms, including obesity, diabetes mellitus and hyperlipidemia have been reported.
Although major population surveys and meta-analysis have suggested an increased risk for iron deficiency anaemia (IDA), however the relationship between H. pylori infection/its eradication on IDA and other extra-gastrointestinal tract diseases has not been clarified, especially in elderly patients.
This study was aimed to examine the effect of H. pylori eradication therapy on the extra-gastrointestinal factors in elderly patients by a before-after observational study in community medicine.
Medical records (1 May 2013-31 January 2014) of 130 patients who underwent H. pylori eradication therapy with 2-year after-eradication observation in our institute were reviewed. Data on sex; age; body weight; body mass index (BMI); mean corpuscular volume (MCV); total protein; low-density lipoprotein cholesterol, triglyceride, haemoglobin A1c and haemoglobin levels and gastric hyperplastic polyps (GHPs) at eradication was extracted. Two-year after-eradication change in data was analysed by paired-sample t-test; relationship between GHPs and subclinical IDA improvement was evaluated.
The mean patient age (median, interquartile range) at eradication was 69.6 (71.5, 64-77) years. Paired-sample t-tests showed that body weight, BMI and MCV increased by 0.52 kg (P = 0.018), 0.25 kg/m2 (P = 0.006) and 0.83 fL (P < 0.001), respectively. The nonparametric Mann-Whitney test showed no significant difference in the change rate of MCV after eradication between the groups with and without GHPs (P = 0.892).
H. pylori eradication therapy prevented weight loss and subclinical IDA in elderly individuals, therefore, the eradication should be considered even for those elder patients.
For the future perspective, as the development of an aging society may be upcoming event in the near future, H. pylori eradication therapy may be a useful approach for preventing weight loss and frailty in elderly individuals to keep their quality of life and health.